Name | N-(3-chloro-5-fluorophenyl)-4-nitrobenzo[c][1,2,5]oxadiazol-5-amine |
---|---|
Synonyms | HIF2α-IN-2 |
Description | TC-S 7009 is a potent and selective HIF-2α inhibitor with a Kd of 81 nM. TC-S 7009 is more selective for HIF-2α than HIF-1α (Kd ≫ 5 μM). TC-S 7009 disrupts HIF-2α heterodimerization, decreases DNA-binding activity, and reduces HIF-2α target gene expression[1][2]. |
---|---|
Related Catalog | |
Target |
Kd: 81 nM (HIF-2α)[1] |
In Vitro | TC-S 7009 (0-100 µM; 72 hours; HPF cells) treatment shows greater inhibition of cell proliferation in hypoxic conditions than that in normoxic conditions[2]. TC-S 7009 (50 μM) treatment almost completely inhibits the hypoxia-induced NFATc2 nuclear translocation[2]. Cell Proliferation Assay[2] Cell Line: HPF cells in hypoxic conditions Concentration: 0-100 µM Incubation Time: 72 hours Result: Showed greater inhibition of cell proliferation in hypoxic conditions than that in normoxic conditions. |
References |
Molecular Formula | C12H6ClFN4O3 |
---|---|
Molecular Weight | 308.65200 |
Exact Mass | 308.01100 |
PSA | 96.77000 |
LogP | 4.26330 |
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H301-H413 |
Precautionary Statements | P301 + P310 |
RIDADR | UN 2811 6.1 / PGIII |